Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Is protracted low-dose temozolomide feasible in glioma patients?

Is protracted low-dose temozolomide feasible in glioma patients? Neurology. 2006 Aug 08; 67(3):543-4; author reply 543-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.